Twice-yearly access, availability, and coverage support
YEZTUGO is given as two subcutaneous injections every 6 months after starter dosing. On day 1, the patient receives two oral tablets and two injections in a medical setting. On day 2, two more oral tablets are taken at home. HIV testing is required before starting and before each injection visit.
Before a YEZTUGO injection visit is scheduled, the care team needs to confirm medication access, benefit routing, storage and handling requirements, trained staff availability, HIV testing, billing setup, and the follow-up timing for the next six-month dose.
Gilead Advancing Access can help with benefits investigations, prior authorization, co-pay program enrollment for eligible commercially insured patients, and medication-assistance pathways. The program can be reached at 1-800-226-2056.